Position in ARVN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$135,610
+$116,433 QoQ
Shares Held
16,319
+909.2% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#123
of 198 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Derivatives in ARVN
reported options exposure · as of Jun 30, 2026CallValue
$51,522
CallShares
6,200
PutValue
$69,804
PutShares
8,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. ARVN ranks #99 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in ARVN
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $135,610 | 16,319 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $69,804 | 8,400 | Put | Sole | 2026-08-03 | |
| 2026-06-30 | $51,522 | 6,200 | Call | Sole | 2026-08-03 | |
| 2025-12-31 | $103,182 | 8,700 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $77,090 | 6,500 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $19,177 | 1,617 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $643,260 | 75,500 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $32,376 | 3,800 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $104,174 | 12,227 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,040 | 4,761 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $117,760 | 16,000 | Put | Sole | 2025-08-13 | |
| 2025-06-30 | $675,648 | 91,800 | Call | Sole | 2025-08-13 | |
| 2025-03-31 | $54,756 | 7,800 | Call | Sole | 2025-05-14 | |
| 2025-03-31 | $72,306 | 10,300 | Put | Sole | 2025-05-14 | |
| 2025-03-31 | $873,302 | 124,402 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $44,334 | 1,800 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $671,044 | 27,245 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $669,679 | 25,157 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,427,792 | 34,588 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $98,784 | 2,400 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $453,377 | 11,015 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $90,156 | 3,300 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $448,785 | 16,427 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $5,464 | 200 | Put | Sole | 2023-05-15 | |
| 2022-12-31 | $106,051 | 3,100 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $95,788 | 2,800 | Put | Sole | 2023-02-14 | |
| 2022-06-30 | $2,606,170 | 61,919 | Shares | Sole | 2022-08-19 | |
| 2021-12-31 | $1,301,590 | 15,846 | Shares | Sole | 2022-05-27 | |
| No filing history on record for this holder in this stock. | ||||||